MRI can spare many patients with rectal cancer from invasive surgery

Share this article Specific initiatives and programmes from the partnership are anticipated in 2024. Credit: Paul reverve /Shutterstock.com. PharmaLink has partnered with Recall Results on

In ear­ly-stage tri­als called dose es­ca­la­tion stud­ies, drug de­vel­op­ers usu­al­ly want to test pro­gres­sive­ly high­er dos­es of their ther­a­pies. Not Per­spec­tive Ther­a­peu­tics. The ra­dio­phar­ma biotech

Roche’s breast can­cer com­bi­na­tion of in­avolis­ib plus pal­bo­ci­clib and ful­ves­trant showed off new da­ta Fri­day, with the com­pa­ny tout­ing a 57% re­duc­tion in the risk